+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

U.S. Compounding Pharmacies Market Size, Share, & Trends Analysis Report By Type (503A, 503B), By Therapeutic Area, By Age Cohort, Compounding Type, By Sterility, And Segment Forecasts, 2024 - 2030

  • PDF Icon

    Report

  • 100 Pages
  • August 2024
  • Region: United States
  • Grand View Research
  • ID: 5999010
Description Jump to:

U.S. Compounding Pharmacies Market Growth & Trends

The U.S. compounding pharmacies market size is anticipated to reach USD 7.18 billion by 2030 and is anticipated to grow at a CAGR of 4.89% from 2024 to 2030. The market is poised for substantial growth, driven by rising awareness and adoption of compounded medications. The growing demand stems from increasing prescription volumes, frequent drug shortages, and manufacturer discontinuations of key medications. These shortages, impaired by supply chain disruptions and manufacturing delays issues that were intensified by the COVID-19 pandemic have increased the critical role of compounding pharmacies.

According to the FDA, drug shortages increased due to manufacturing restrictions, raw material shortages, and logistic delays during the pandemic. As a result, compounding pharmacies gained more opportunities to fill these gaps in drug availability. The FDA even issued temporary guidance allowing federally and state-licensed pharmacies to compound certain medications for hospitalized patients during public health emergencies. This combination of rising demand and regulatory support is expected to drive market expansion.

U.S. Compounding Pharmacies Market Report Highlights

  • Based on type, the 503A segment held the largest revenue share in 2023. This is attributed to the rising demand for personalized medications tailored to individual patient needs.
  • Based on therapeutic area, the pain management segment dominated the market with the largest market share in 2023 due to its specialized approaches in alleviating the side effects of standard pain management medications.
  • Based on age cohort, the adult segment dominated the market with the largest revenue share in 2023 due to factors such as allergies, specific dosage requirements, and preferences for other forms of medication.
  • Based on compounding type, the pharmaceutical ingredient alteration (PIA) segment dominated the U.S. compounding pharmacies market in 2023 due to the high demand for customized drugs from patients with special needs.
  • Based on sterility, the sterile segment dominated the market with the largest revenue share in 2023 due to the significant demand for intravenous sterile planning required by geriatric and pediatric patients.
  • For instance, in February 2023, Harrow Health, Inc., a prominent U.S. eyecare pharmaceutical company, launched its patent-pending, next-generation compounded Atropine formulations, now accessible through its compounding and mail-order pharmacy subsidiary, ImprimisRx.

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets


This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Type
1.2.2. Therapeutic Area
1.2.3. Age Cohort
1.2.4. Compounding Type
1.2.5. Sterility
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. Internal Database
1.5.3. Secondary Sources & Third-Party Perspectives
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.2.1. Market Driver Analysis
3.2.1.1. Increasing demand for personalized medications
3.2.1.2. Growing importance of pharmaceutical compounding in promoting medication adherence
3.2.1.3. Increasing supportive government policies
3.2.2. Market Restraint Analysis
3.2.2.1. Quality and safety concerns
3.2.2.2. Chances of human errors or medication errors
3.2.3. Market Opportunity Analysis
3.2.4. Market Challenges Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
Chapter 4. Type Business Analysis
4.1. Type Segment Dashboard
4.2. U.S. Compounding Pharmacies Market: Type Movement Analysis
4.3. U.S. Compounding Pharmacies Market Size & Trend Analysis, by Type, 2018 - 2030 (USD Million)
4.4. 503A
4.4.1. 503A Market, 2018 - 2030 (USD Million)
4.5. 503B
4.5.1. 503B Market, 2018 - 2030 (USD Million)
Chapter 5. Therapeutic Area Business Analysis
5.1. Therapeutic Area Segment Dashboard
5.2. U.S. Compounding Pharmacies Market: Therapeutic Area Movement Analysis
5.3. U.S. Compounding Pharmacies Market Size & Trend Analysis, by Therapeutic Area, 2018 - 2030 (USD Million)
5.4. Pain Management
5.4.1. Pain Management Market, 2018 - 2030 (USD Million)
5.5. Hormone Replacement Therapy
5.5.1. Hormone Replacement Therapy Market, 2018 - 2030 (USD Million)
5.6. Specialty Drugs
5.6.1. Specialty Drugs Market, 2018 - 2030 (USD Million)
5.7. Dermatology
5.7.1. Dermatology Market, 2018 - 2030 (USD Million)
5.8. Nutritional Supplements
5.8.1. Nutritional Supplements Market, 2018 - 2030 (USD Million)
5.9. Others
5.9.1. Others Market, 2018 - 2030 (USD Million)
Chapter 6. Age Cohort Business Analysis
6.1. Age Cohort Segment Dashboard
6.2. U.S. Compounding Pharmacies Market: Age Cohort Movement Analysis
6.3. U.S. Compounding Pharmacies Market Size & Trend Analysis, by Age Cohort, 2018 - 2030 (USD Million)
6.4. Pediatric
6.4.1. Pediatric Market, 2018 - 2030 (USD Million)
6.5. Adult
6.5.1. Adult Market, 2018 - 2030 (USD Million)
6.6. Geriatric
6.6.1. Geriatric Market, 2018 - 2030 (USD Million)
Chapter 7. Compounding Type Business Analysis
7.1. Compounding Type Segment Dashboard
7.2. U.S. Compounding Pharmacies Market: Compounding Type Movement Analysis
7.3. U.S. Compounding Pharmacies Market Size & Trend Analysis, by Compounding Type, 2018 - 2030 (USD Million)
7.4. Pharmaceutical Ingredient Alteration (PIA)
7.4.1. Pharmaceutical Ingredient Alteration (PIA) Market, 2018 - 2030 (USD Million)
7.5. Currently Unavailable Pharmaceutical Manufacturing (CUPM)
7.5.1. Currently Unavailable Pharmaceutical Manufacturing (CUPM) Market, 2018 - 2030 (USD Million)
7.6. Pharmaceutical Dosage Alteration (PDA)
7.6.1. Pharmaceutical Dosage Alteration (PDA) Market, 2018 - 2030 (USD Million)
Chapter 8. Sterility Business Analysis
8.1. Sterility Segment Dashboard
8.2. U.S. Compounding Pharmacies Market: Sterility Movement Analysis
8.3. U.S. Compounding Pharmacies Market Size & Trend Analysis, by Sterility, 2018 - 2030 (USD Million)
8.4. Sterile
8.4.1. Sterile Market, 2018 - 2030 (USD Million)
8.5. Non Sterile
8.5.1. Non Sterile Market, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Company Market Position Analysis
9.3. Strategy Mapping
9.4. Company Profiles/Listing
9.4.1. Avella Specialty Pharmacy
9.4.1.1. Overview
9.4.1.2. Financial Performance
9.4.1.3. Service Benchmarking
9.4.1.4. Strategic Initiatives
9.4.2. Central Admixture Pharmacy Services, Inc.
9.4.2.1. Overview
9.4.2.2. Financial Performance
9.4.2.3. Service Benchmarking
9.4.2.4. Strategic Initiatives
9.4.3. Clinigen Limited
9.4.3.1. Overview
9.4.3.2. Financial Performance
9.4.3.3. Service Benchmarking
9.4.3.4. Strategic Initiatives
9.4.4. Fagron
9.4.4.1. Overview
9.4.4.2. Financial Performance
9.4.4.3. Service Benchmarking
9.4.4.4. Strategic Initiatives
9.4.5. Fresenius Kabi USA
9.4.5.1. Overview
9.4.5.2. Financial Performance
9.4.5.3. Service Benchmarking
9.4.5.4. Strategic Initiatives
9.4.6. ImprimisRx (Harrow Health, Inc.)
9.4.6.1. Overview
9.4.6.2. Financial Performance
9.4.6.3. Service Benchmarking
9.4.6.4. Strategic Initiatives
9.4.7. PenCol Pharmacy
9.4.7.1. Overview
9.4.7.2. Financial Performance
9.4.7.3. Service Benchmarking
9.4.7.4. Strategic Initiatives
9.4.8. Sixth Avenue Medical Pharmacy
9.4.8.1. Overview
9.4.8.2. Financial Performance
9.4.8.3. Service Benchmarking
9.4.8.4. Strategic Initiatives
9.4.9. Triangle Compounding
9.4.9.1. Overview
9.4.9.2. Financial Performance
9.4.9.3. Service Benchmarking
9.4.9.4. Strategic Initiatives
9.4.10. Vertisis Custom Pharmacy
9.4.10.1. Overview
9.4.10.2. Financial Performance
9.4.10.3. Service Benchmarking
9.4.10.4. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 U.S. compounding pharmacies market, by type, 2018 - 2030 (USD Million)
Table 4 U.S. compounding pharmacies market, by therapeutic area, 2018 - 2030 (USD Million)
Table 5 U.S. compounding pharmacies market, by age cohort, 2018 - 2030 (USD Million)
Table 6 U.S. compounding pharmacies market, by compounding type, 2018 - 2030 (USD Million)
Table 7 U.S. compounding pharmacies market, by sterility, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 Model details
Fig. 8 U.S. Compounding Pharmacies market segmentation
Fig. 9 Market snapshot
Fig. 10 Segment snapshot
Fig. 11 Competitive landscape snapshot
Fig. 12 Market dynamics
Fig. 13 Market driver relevance analysis (current & future impact)
Fig. 14 Market restraint relevance analysis (current & future impact)
Fig. 15 PESTLE analysis
Fig. 16 Porter’s five forces analysis
Fig. 17 U.S. compounding pharmacies market: Type outlook and key takeaways
Fig. 18 U.S. compounding pharmacies market: Type movement analysis
Fig. 19 503A market revenue, 2018 - 2030 (USD Million)
Fig. 20 503B market revenue, 2018 - 2030 (USD Million)
Fig. 21 U.S. compounding pharmacies market: Therapeutic area outlook and key takeaways
Fig. 22 U.S. compounding pharmacies market: Therapeutic area movement analysis
Fig. 23 Hormone replacement therapy market revenue, 2018 - 2030 (USD Million)
Fig. 24 Pain management market revenue, 2018 - 2030 (USD Million)
Fig. 25 Specialty drugs market revenue, 2018 - 2030 (USD Million)
Fig. 26 Dermatology market revenue, 2018 - 2030 (USD Million)
Fig. 27 Nutritional supplements market revenue, 2018 - 2030 (USD Million)
Fig. 28 Others market revenue, 2018 - 2030 (USD Million)
Fig. 29 U.S. compounding pharmacies market: Age cohort outlook and key takeaways
Fig. 30 U.S. compounding pharmacies market: Age cohort movement analysis
Fig. 31 Pediatric market revenue, 2018 - 2030 (USD Million)
Fig. 32 Adult market revenue, 2018 - 2030 (USD Million)
Fig. 33 Geriatric market revenue, 2018 - 2030 (USD Million)
Fig. 34 U.S. compounding pharmacies market: Compounding type outlook and key takeaways
Fig. 35 U.S. compounding pharmacies market: Compounding type movement analysis
Fig. 36 Pharmaceutical Ingredient Alteration (PIA) market revenue, 2018 - 2030 (USD Million)
Fig. 37 Currently Unavailable Pharmaceutical Manufacturing (CUPM) market revenue, 2018 - 2030 (USD Million)
Fig. 38 Pharmaceutical Dosage Alteration (PDA) market revenue, 2018 - 2030 (USD Million)
Fig. 39 Others market revenue, 2018 - 2030 (USD Million)
Fig. 40 U.S. compounding pharmacies market: Sterility outlook and key takeaways
Fig. 41 U.S. compounding pharmacies market: Sterility movement analysis
Fig. 42 Sterile market revenue, 2018 - 2030 (USD Million)
Fig. 43 Non sterile market revenue, 2018 - 2030 (USD Million)
Fig. 44 Company categorization
Fig. 45 Company market position analysis
Fig. 46 Strategy mapping

Companies Mentioned

  • Avella Specialty Pharmacy
  • Central Admixture Pharmacy Services, Inc.
  • Clinigen Limited
  • Fagron
  • Fresenius Kabi USA
  • ImprimisRx (Harrow Health, Inc.)
  • PenCol Pharmacy
  • Sixth Avenue Medical Pharmacy
  • Triangle Compounding
  • Vertisis Custom Pharmacy

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages100
PublishedAugust 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 5.13 Billion
Forecasted Market Value ( USD ) by 2030 $ 7.18 Billion
Compound Annual Growth Rate4.8%
Regions CoveredUnited States
No. of Companies Mentioned10

Related Topics

Related Reports

Sterile Compounding Pharmacies Global Market Report 2024 - Product Image

Sterile Compounding Pharmacies Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
United States Compounding Pharmacies Market Report and Forecast 2024-2032 - Product Image

United States Compounding Pharmacies Market Report and Forecast 2024-2032

  • Report
  • 172 Pages
  • United States
From
Compounding Pharmacy - Global Strategic Business Report - Product Image

Compounding Pharmacy - Global Strategic Business Report

  • Report
  • 187 Pages
  • Global
From
Compounding Pharmacies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Compounding Pharmacies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 245 Pages
  • Global
Automated Compounding Devices Market by Component, Product Type, Application, End-User - Global Forecast 2025-2030 - Product Image

Automated Compounding Devices Market by Component, Product Type, Application, End-User - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From

About the Market

Compounding Pharmacies are a subset of Drugstores and Pharmacies that specialize in the preparation of customized medications. Compounding Pharmacies are able to create medications tailored to the specific needs of a patient, such as altering the dosage form, strength, or flavor of a medication. Compounding Pharmacies also offer medications that are not commercially available, such as those that are no longer manufactured or those that are not available in the desired dosage form. Compounding Pharmacies are regulated by the United States Pharmacopeia and the Food and Drug Administration. Compounding Pharmacies are often used by patients who have difficulty taking commercially available medications, such as those with allergies or sensitivities to certain ingredients. Compounding Pharmacies also provide medications for veterinary use, such as medications for animals that are not available commercially. Some companies in the Compounding Pharmacies market include Apothecary By Design, B&B Pharmaceuticals, and Wedgewood Pharmacy. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.